Blog

Categories
  1. How to access pirtobrutinib before its approval in Europe & the UK

    Pirtobrutinib is not yet approved and available in the EU and UK. But doesn't mean you can't access it immediately. Read on for all your options.

    Read more »
  2. Belzutifan approval in the UK & Ireland: What's the status and what does it mean for you?

    Belzutifan is currently approved as an orphan medicine in the UK. Find out when it will be widely available on the market, and what that means for you.

    Read more »
  3. Enhertu's UK Approval status & What It Means for You as a Patient

    Everything you should know about Enhertu in the UK. What is it approved for, and how can you access it?

    Read more »
  4. Can Enhertu Treat Ovarian Cancer? All the Data, None of the Hype.

    How effective is Enhertu for ovarian cancer, and can your doctor prescribe it before it's approved for this indication? All the answers - here.

    Read more »
  5. How to Navigate the EMA's Adakveo Revocation and Its Impact on You

    What happens after Adakveo's revocation in the EU? Understand the reasons for the EMA's decision, and the Adakveo alternatives you have.

    Read more »
  6. Adakveo vs Oxbryta: Getting to know your crizanlizumab alternatives

    Find out the key similarities and differences between Adakveo and Oxbryta, including how to access both medicines.

    Read more »
  7. Is dostarlimab available in Belgium (and what to do in the meantime)?

    When will dostarlimab be available in Belgium? Find out all the ways to access it in the meantime.

    Read more »
  8. Is dostarlimab available in the UK (and what to do in the meantime)?

    When will dostarlimab be available in the UK? Learn everything worth knowing about accessing the medicine.

    Read more »
  9. Teclistamab in Germany: When Will It Be Available and All Your Options in the Meantime

    Why teclistamab isn't available in Germany (yet) and how to access it in the meantime.

    Read more »
  10. What types of cancer is dostarlimab used for? The only overview you need.

    What types of cancer can dostarlimab treat? See all the latest approvals and research about this novel cancer treatment.

    Read more »
  11. Jemperli vs Keytruda for endometrial cancer: What’s the difference?

    A simple overview of Jemperli and Keytruda as treatment options for endometrial cancer. Find out how they work, how efficient they are, and how much they cost.

    Read more »
  12. Can Opzelura be used with Dupixent?

    Is it possible to combine Dupixent with Opzelura in your eczema treatment? All your questioned answered.

    Read more »
  13. Can I use Opzelura cream for psoriasis?

    Everything you and your doctor should know about the potential usage od Opzelura for psoriasis.

    Read more »
  14. Is Opzelura available in the UK?

    All vitiligo patients in the UK should know about Opzelura avaiability on the market, and the alternatives in the meantime.

    Read more »
  15. Briumvi vs Ocrevus vs Kesimpta: Understanding Your MS Treatment Options

    Understand the similarities and differences between Briumvi, Ocrevus and Kesimpta in one simple overview.

    Read more »
  16. Can Jakavi be used instead of Opzelura? The short-but-full story.

    Can you use Jakavi for your vitiligo, while waiting for Opzelura to become available on the European market? All you need to know.

    Read more »
  17. Can Leqembi be administered at home? Home infusions, autoinjectors, and more.

    Is it possible to get a Leqembi home infusion? Will you be able to inject Leqembi at home by yourself soon? Learn all we know.

    Read more »
  18. What’s the difference between Leqembi and Aduhelm? A simple overview.

    The difference between Leqembi and Aduhelm, simply explained. How do these Alzheimer's medicines work, where are they approved, and how can you access them?

    Read more »
  19. Changing the story: How nitisinone brings hope back for HT-1 and AKU patients

    How nitisinone tablets give hope to HT-1 and AKU patients. Now also available for free in India, Pakistan, Bangladesh and Sudan.

    Read more »
  20. Charting the Course: A Clear Guide to Alzheimer's Treatment by Stage

    Find hope and support with Alzheimer's treatment options. Learn about innovative therapies and resources to manage symptoms and improve quality of life.

    Read more »
  21. Your complete guide to Briumvi, the newest approved MS treatment

    Everything you need to know about Briumvi, the latest approved CD20 antibody for the treatment of multiple sclerosis.

    Read more »
  22. Breakthrough or hype? A simple look at anti-amyloid therapy for Alzheimer's disease.

    Anti-amyloid therapy for Alzheimer's, explained simply. What is it, how does it work, which one is approved, and how can you access it?

    Read more »
  23. How to access Leqembi before it's available across the EU

    All the safe and legal options to access Leqembi while it's waiting for its EU approval.

    Read more »
  24. Your Complete Guide to Leqembi: An Alzheimer's Drug Worth Remembering

    All you need to know about Leqembi, the latest approved Alzheimer's medicine.

    Read more »
  25. Emerging NSCLC treatments: Here are the latest drugs to keep an eye on

    A simple overview of standard and emerging NSCLC treatments.

    Read more »
  26. KRAS inhibitors for lung cancer: All about the new treatments bringing hope

    Understanding KRAS inhibitors for lung cancer: how they work, which ones are approved, and what's coming?

    Read more »
  27. What's the difference between Sotorasib and Adagrasib? A simple overview.

    Sotorasib vs Adagrasib: A side-by-side comparison of the latest Alzheimer's medicines.

    Read more »
  28. Your complete guide to Lumakras (sotorasib) and how to get it

    Anti-amyloid therapy for Alzheimer's, explained simply. What is it, how does it work, which one is approved, and how can you access it?

    Read more »
  29. The Medicine Access Masterclass is coming soon

    The Medicine Access Masterclass is a unique overview of early medicine access options of innovative medicine which cannot be found anywhere else.

    Read more »
  30. What we know about Paxlovid (nirmatrelvir and ritonavir): oral antiviral against COVID-19 | New COVID-19 Medicine

    Paxlovid is an antiviral administered orally to patients who are ill with COVID-19 or have been exposed to the coronavirus SARS-CoV-2 and are at risk of developing severe illness. The manufacturer, pharmaceutical and biotechnology giant Pfizer, developed it to patients avoid severe illness which can lead to hospitalization and death. It is meant to be administered at the first sign of infection.

    Read more »
US United States 1